Therefore, these results demonstrate that the sequential ERK-RSK1-NF-κB pathway mediates PMAstimulated megakaryocytic differentiation of K562 cells.
INTRODUCTION
Hematopoiesis in vertebrates, which is a complicated multistep process, is a paradigm for the development of diverse specialized cell types from multipotent progenitors. How specific signaling pathways control hematopoiesis is a major focus in the area of hematopoiesis. A widely used model system for studying early steps in megakaryocytic differentiation of hematopoietic stem cells is PMAinduced differentiation of K562 cells (1) . It has been well documented that K562 cells, human chronic myelogenous leukemic cells carrying Philadelphia chromosome (2) , can be induced by phorbol 12-myristate 13-acetate (PMA), a protein kinase C (PKC) activator, to differentiate into cells with megakaryocytic characteristics (3) (4) (5) (6) . These include changes in cell morphology and adhesive properties, cell growth arrest, and expression of markers associated with megakaryocyte.
In spite of recent advances in studying the molecular events associated with PMA-induced megakaryocytic differentiation of K562 cells, the exact signaling mechanism is not fully understood. We have previously shown that PMA-induced differentiation of K562 cells is inhibited by the treatment with pyrrolidine dithiocarbamate, an inhibitor of NF-κB (7) , and NF-κB subunit-transfected cells are more sensitive to PMA-induced differentiation than their parental cells, and PMA-induced differentiation was enhanced by the pretreatment with IκBα antisense oligonucleotide (8) . In contrast, it has been reported recently that overexpression of the constitutively active mutants of MEK induce megakaryocytic differentiation in K562 cells, and blockade of MEK activation by PD98059 reverses both the growth arrest and the morphological changes of K562 cells induced by PMA treatment (9) (10) (11) . This suggested that a sustained activation of ERK/MAPK pathway is necessary to induce a differentiation program along the megakaryocyte lineage in K562 cells.
In our previous study, although there were no differences in the basal or PMA-stimulated activities of ERK/MAPK between the parental and NF-κB subunit-transfected K562 cells, PMA-induced differentiation was almost completely inhibited in both parental and NF-κB subunit-transfected cells after preventing PMA-stimulated activation of MAP kinase by the pretreatment of PD98059 (8) .
Therefore, it is likely that the MAP kinase pathway is required for the PMA-induced megakaryocytic differentiation of K562 cells, suggesting that activation of MAP kinase works through NF-κB activation, or activation of both NF-κB and MAP kinase pathways are involved.
Two recent reports have shown that the 90 kDa ribosomal S6 kinase (RSK1) is an essential kinase required for phosphorylation and subsequent degradation of IκBα in response to mitogens including PMA (12, 13) . Therefore, RSK1 is a good candidate to connect the ERK/MAPK pathway and the NF-κB pathway in PMA-induced megakaryocytic differentiation of K562 cells. In this study, the role of RSK1 in PMA-induced megakaryocytic differentiation of K562 cells was investigated.
MATERIALS AND METHODS
Cell Culture-K562 cells were grown in suspension in RPMI 1640 medium (Gibco, BRL, Inc.) supplemented with 10% (v/v) heat-inactivated fetal bovine serum (FBS, Gibco, BRL, Inc.), 100 units/ml penicillin, and 100 µg/ml streptomycin (Sigma Chemical Co.). For the experiment, exponentially growing K562 cells were collected (1,200 x g, 10 min) and resuspended in fresh culture medium.
Ribosomal S6 kinase assay-The S6 kinase assays were performed using S6 kinase Assay Kit from Upstate biotechnology, Inc., according to manufacturer's protocol. Cells (1x10 6 /ml) were harvested, washed twice in ice-cold PBS and then scraped into 150 µl of lysis buffer (20 mM Tris, pH7.4, 150 mM NaCl, 5 mM EDTA, 1 mM EGTA, 1% Triton X-100, 2.5 mM sodium pyrophosphate, 1 mM β-glycerophosphate, 1 mM Na 3 Vo 4 , 1 µg/ml leupeptin, and 1 mM PMSF). After incubation for 30 min at Dried papers were wrapped, and radioactivity was detected with Molecular Imager (GS-525, Bio-Rad).
Plasmids and DNA transfection-pcDNA3-Rsk1, pcDNA3-Rsk1-D205N and pCMV-IκBα-32A36A (kindly donated by Dr. Zantema, Leiden University, Netherlands) have been described elsewhere (14) .
pcDNA3-Rsk1-D205N has a mutated ATP binding site of the amino-terminal kinase domain of RSK1, and pCMV-IκBα-S32AS36A contains mutated alanines at the serine phosphorylation sites. pCMV-p50 and -p65 are expression plasmids in which p50 and p65 subunit of NF-κB were cloned in HindIII/XbaI of pRc/CMV (Invitrogen), respectively (8) . Electroporation was carried out using an Electroporator II (Invitrogen) at 1,500 V/cm, 50 µF condition. After electroporation, stable transformants were selected with G418 (475 µg/ml) and identified by western blot analysis using polyclonal antibody against RSK1 (Upstate biotechnology, Inc.) and IκBα (Santa Cruz Biotechnology, Inc. California, USA).
Preparation of nuclear extracts and electrophoretic mobility shift assays-Nuclear extracts were prepared as previously described (8) . 2 x 10 6 cells were harvested and washed with cold phosphate buffered saline and resuspended in 50 µl of lysis buffer (10 mM HEPES, pH 7.9, 1.5 mM MgCl 2 , 10 mM KCl, 0.5 mM dithiothreitol (DTT), and 0.5 mM phenylmethylsulphonyl fluoride (PMSF)). The cells were allowed to be swollen on ice for 10 min, after which the cells were resuspended in 30 µl of lysis buffer containing 0.05% Nonidet P40. Then the tube was vigorously mixed on a vortex machine 3 times for 10 sec, and the homogenate was centrifuged at 250 x g for 10 min to pellet the nuclei. The nuclear pellet was resuspended in 40 µl of ice-cold nuclear extraction buffer (5 mM HEPES, pH 7.9, 26% glycerol (v/v), 1. 
RESULTS
Activation of RSK1 after treatment of PMA-As we previously mentioned, the ribosomal S6 kinase (RSK1) is a good candidate connecting the ERK/MAPK pathway and the NF-κB pathway, both of which are known to be involved in PMA-induced megakaryocytic differentiation of K562 cells. Therefore, we examined whether RSK1 could be activated by PMA in K562 cells.
To measure the PMA-stimulated RSK1 activity, an immune complex kinase assay was done. When K562 cells were treated with various concentrations of PMA for 1 h, RSK1 was activated in a dosedependent manner up to 10 nM of PMA (Fig. 1A) . After treatment with 10 nM PMA for the indicated time (Fig. 1B) , a sustained activation of RSK1 was shown over at least 12 h with approximately 10 fold activation at 1 h peak time. This result is consistent with sustained activation of the ERK/MAPK during PMA-induced megakaryocytic differentiation of K562 cells (11) . 
Isolation of wild-type or dominant inhibitory mutant of RSK1-transfected K562 cells-To

Effect of wild-type or dominant inhibitory mutant of RSK1 on PMA-induced activation of NF-κB in
K562 cells-Since we have suggested that PMA-induced megakaryocytic differentiation of K562 cells is dependent on the NF-κB pathway (8), NF-κB mobility shift assay was done in order to examine whether NF-κB activity of K562 cells would be modulated after transfection with wild-type RSK1 or dominant inhibitory mutant (D205N) of RSK1. Overexpression of RSK1 or RSK1 (D205N) enhanced or suppressed PMA-stimulated NF-κB activity, respectively (Fig. 3, upper panel) . Consistently, degradation of IκBα was enhanced or suppressed by overexpression of RSK1 or RSK1 (D205N) (Fig. 3, lower panel) . These results are consistent with the RSK1 activities of K562-RSK1 and K562-RSK1 (D205N) cells (Fig 2. A) , indicating that activity of NF-κB could be modulated downstream of RSK1 in K562 cells. (Fig. 4A ). K562 and K562-IκBα (S32A/S36A) cells had comparable activities of RSK1, and K562-RSK1 and K562-RSK1/IκBα (S32A/S36A) cells had comparable activities of RSK1 (Fig. 4B ). As shown in Fig. 4C , overexpression of IκBα (S32A/S36A) inhibited both PMAstimulated NF-κB activation and RSK1-mediated NF-κB activation.
Then, we have examined the effect of RSK1 and NF-κB activities on PMA-induced megakaryocytic differentiation of K562 cells. PMA-induced differentiation of K562 cells was enhanced or suppressed by overexpression of RSK1 or RSK1 (D205N), respectively, as shown by morphology (Fig. 5A ) and nonspecific esterase assay (Fig. 5B) , indicating that PMA-induced differentiation of K562 cells could be affected by RSK1 activity. Overexpression of IκBα (S32A/S36A) prevented morphological change and activation of non-specific esterase induced by PMA and also inhibited RSK1-mediated differentiation of K562 cells (Fig. 5A, and 5B ). In addition, when K562 cells were transfected transiently with both subunits of NF-κB, some cells underwent morphological changes and were adherent to culture dish (Fig.   5C ). These results demonstrate that RSK/NF-κB pathway mediates PMA-induced megakaryocytic differentiation of K562 cells.
Effect of ERK activity on RSK1 activation and RSK1-mediated NF-κB activation of K562 cells-If
the sequential ERK-RSK-NF-κB pathway plays a role in PMA-induced megakaryocytic differentiation of K562 cells, pretreatment with PD98059, a specific inhibitor of MEK that prevents the activation of MEK and subsequently the activation of ERK/MAPK, would lead to prevention of the activation of ERK-RSK-NF-κB pathway and subsequent megakaryocytic differentiation of K562 cells induced by PMA. When PMA-stimulated activation of ERK was prevented by the pretreatment with PD98059 in K562 and K562-RSK1 cells (Fig. 6A) , PMA-stimulated activation of RSK1 and NF-κB was also prevented (Fig. 6B and 6C, respectively) , indicating that activation of RSK1 and NF-κB depends on ERK/MAPK activation. In addition, PMA-induced megakaryocytic differentiation was prevented by the pretreatment with PD98059 in both K562 and K562-RSK1 cells (Fig. 6D) . From these results, it could be concluded that PMA-stimulated activation of RSK1 and NF-κB is ERK-dependent, and sequential activation of ERK, RSK1 and NF-κB mediates PMA-induced megakaryocytic differentiation of K562 cells.
Flow cytometric analysis of the effect of overexpression of RSK1, dominant inhibitory mutants of RSK1 and IκBα and PD98059 on CD41 expression-To evaluate the role of the ERK-RSK-NF-κB
pathway in PMA-induced megakaryocytic differentiation of K562 more specifically, flow cytometric analysis on expression of CD41, megakaryocytic surface marker, was performed (Fig. 7) . Consistent with the morphology and non-specific esterase assay, overexpression of RSK1 enhanced the expression of CD41 induced by PMA (Fig. 7B) , while overexpression of RSK1 (D205N) suppressed the expression of CD41 (Fig. 7C) . Overexpression of IκBα (S32A/S36A) inhibited the expression of CD41 induced by PMA (Fig. 7D ) and enhanced by overexpression of RSK1 (Fig. 7E) . In addition, PMA-induced CD41 expression was prevented by the pretreatment with PD98059 in both parental and RSK1-transfected K562 cells (Fig. 7F) . Similar results were observed in CD61 expression (data not shown). These results confirmed that PMA-induced megakaryocytic differentiation is dependent on the ERK-RSK-NF-κB pathway.
DISCUSSION
The signaling mechanism which mediates the PMA-induced megakaryocytic differentiation of K562 cells is still controversial. We have proposed that PMA-induced megakaryocytic differentiation of K562 cells is dependent on NF-κB pathway (8) . In contrast, others (9) (10) (11) Previously we demonstrated that the NF-κB pathway is responsible for PMA-induced differentiation of K562 cells (8) and it has been shown that RSK1 is a signal-inducible IκBα kinase required for phosphorylation and subsequent degradation of IκBα, and consequently activation of NF-κB in response to mitogens, including PMA (12, 13) . Therefore, there is a possibility that activation of RSK1 may lead to activation of NF-κB and subsequent induction of megakaryocytic differentiation in K562 cells. In our experiment, activation of NF-κB stimulated by PMA was enhanced or prevented by overexpression of RSK1 or the dominant inhibitory mutant of RSK1 (D205N), respectively. These results were followed by an increased or decreased differentiation of K562 cells as demonstrated with morphology, non-specific activity and expression of megakaryocytic markers, suggesting that RSK1 plays an important role in PMA-induced megakaryocytic differentiation.
Since RSK was discovered in Xenopus laevis oocytes as an intracellular kinase activity that phosphorylated the 40S ribosomal subunit protein S6 (18), diverse substrates have been identified, including transcription factors like the cAMP response element-binding protein (CREB) (19) , the estrogen receptor-α (ERα) (20) , IκBα/NF-κB and c-Fos (12, 13) , the transcriptional coactivator proteins CREB-binding protein (CBP) and p300 (21) , several proteins in the ribosomal complex (22) , glycogen synthase kinase-3 (GSK3) (23), the neural cell adhesion molecule, L1 CAM (24), the Ras GTP: GDPexchange factor, Sos (25) and the p34 cdc2 -inhibitory kinase Myt1 (26) . The diversity of these substrates suggests that RSK is involved in regulation of a wide range of cellular functions (27) . Therefore, it is possible that downstream signals other than the NF-κB pathway might be involved in megakaryocytic differentiation of K562 cells. In the present study, overexpression of IκBα (S32A/S36A), which led to inhibition of RSK1-mediated NF-κB activation, prevented the RSK1-mediated megakaryocytic differentiation of K562 cells, and transfection of K562 cells with p65 subunit of NF-κB induced morphological changes and adherence to culture dish, demonstrating that RSK1 mediates PMAstimulated signal to NF-κB, activation of which leads to induction of megakaryocytic differentiation of K562 cells.
Several groups (9) (10) (11) have demonstrated recently that a sustained activation of the ERK/MAPK pathway is necessary and sufficient to induce a differentiation program along the megakaryocyte lineage in K562 cells, and PD98059 abrogated the differentiation of K562 cells. In the present study, PD98059
prevented the PMA-stimulated activation of RSK1 and NF-κB in both parental and RSK1-transfected K562 cells and subsequent the megakaryocytic differentiation. Therefore, it could be suggested that sequential activation of the ERK-RSK-NF-κB pathway after treatment with PMA resulted in induction of megakaryocytic differentiation of K562 cells. However, we do not know how NF-κB regulates megakaryocytic differentiation. Several megakaryocyte-specific promoters, including platelet factor-4 (28), glycoprotein (GP) IIb (29) (30) (31) (32) , GPIbα (33), thrombopoietin receptor (34) and GPIX (35) have been characterized. These promoters usually contain cis-acting elements regulated by the Sp1 (36), GATA (36) (37) (38) , and Ets (39) families of transcription factors. At least some of these promoters, such as GPIIb and thrombopoietin receptor, have several putative NF-κB binding site. Therefore, studies of transcriptional regulation of megakaryocytic markers via NF-κB would be required to elucidate an exact role of NF-κB in megakaryocytic differentiation.
Previously, we had failed to show induction of megakaryocytic differentiation of K562 cells after transfection with Ha-ras, which activated ERK/MAPK approximately 2.5 fold (7). Although we do not know the threshold activity of ERK/MAPK enough to trigger megakaryocytic differentiation of K562 cells, strong initial activation followed by long-lasting activation of ERK/MAPK is thought to be required. Our failure to demonstrate the induction of differentiation of K562 cells after transfection of Ha-ras led us to study the role of NF-κB during the PMA-induced differentiation of K562 cells, and now we have shown that RSK1 bridges the ERK/MAPK pathway and the NF-κB pathway, each of which has been known to be involved in megakaryocytic differentiation of K562 cells. 
